Docoh
Loading...

AXNX Axonics

News

From Benzinga Pro
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
5 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
SVB Leerink Maintains Outperform on Axonics, Raises Price Target to $85
5 Nov 21
News, Price Target, Analyst Ratings
SVB Leerink analyst Danielle Antalffy maintains Axonics (NASDAQ:AXNX) with a Outperform and raises the price target from $80 to $85.
Needham Maintains Buy on Axonics, Lowers Price Target to $71
5 Nov 21
News, Price Target, Analyst Ratings
Needham analyst Mike Matson maintains Axonics (NASDAQ:AXNX) with a Buy and lowers the price target from $78 to $71.
Axonics Modulation Tech Q3 EPS $(0.38) Beats $(0.43) Estimate, Sales $46.90M Miss $48.97M Estimate
4 Nov 21
Earnings, News
Axonics Modulation Tech (NASDAQ:AXNX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.43) by 11.63 percent. This is a 58.33 percent decrease over losses of $(0.24) per
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
4 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK
Earnings Scheduled For November 4, 2021
4 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
31 Oct 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, IPOs, Top Stories
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
US Patent Office Rejects Three More Axonics' Challenge To Medtronic Patents
23 Sep 21
News, Health Care, Legal, General
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
14 Sep 21
Biotech, M&A, News, Penny Stocks, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13)
U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtronic Patents
13 Sep 21
News, Legal
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectual property (IP) for its sacral
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
10 Sep 21
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9)

Press releases

From Benzinga Pro
Axonics® CEO Raymond W. Cohen Receives Lifetime Entrepreneurial Achievement Award by the Southern California Biomedical Council
30 Nov 21
Press Releases
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that Raymond W. Cohen, chief
Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
17 Nov 21
Press Releases
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced it ranked No. 1 on the Deloitte
Deloitte Unveils 2021 North America Technology Fast 500 Rankings
17 Nov 21
Press Releases
SAN FRANCISCO, Nov. 17, 2021 /PRNewswire/ -- Deloitte today released its "North America Technology Fast 500," an annual ranking of the fastest-growing North American companies in the technology, media,
Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
8 Nov 21
Press Releases
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the Piper Sandler
Axonics® Reports Third Quarter 2021 Financial Results
4 Nov 21
Press Releases
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the third
Axonics® Ranked the Fastest Growing Publicly Traded Company in Orange County
26 Oct 21
Press Releases
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has been named by the Orange County Business
Axonics® to Report Third Quarter 2021 Financial Results on November 4
7 Oct 21
Press Releases
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will report third quarter 2021 financial results
Axonics® Provides Additional Update on Inter Partes Review Proceedings
22 Sep 21
Press Releases
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that the Patent Trial and Appeal
U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtronic Patents
13 Sep 21
Press Releases
DUBLIN, Sept. 13, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectual property (IP)
Axonics® Announces Partial Decision on Inter Partes Review Proceedings
13 Sep 21
Press Releases
Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that the Patent Trial and Appeal